Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.
about
Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-boxRole of CD8 T cell subsets in the pathogenesis of multiple sclerosisMultiple Sclerosis and T Lymphocytes: An Entangled StoryGlial grafting for demyelinating disease.A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in miceMicroglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic networkCognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patientsPromoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS gliaDifferential expression of major histocompatibility complex class I in developmental glioneuronal lesionsModulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating diseaseMeta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Interferon-triggered transcriptional cascades in the oligodendroglial lineage: a comparison of induction of MHC class II antigen between oligodendroglial progenitor cells and mature oligodendrocytes.Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotypeInterferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.Astrocyte immune responses in epilepsy.Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant.Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures.Microglial activation in white matter lesions and nonlesional white matter of ageing brains
P2860
Q24535413-0CD07CC5-8544-4AAD-A6BB-5C8DF5BBB24AQ27010613-465A34E9-74EC-4FB7-9ACE-256498858B44Q28086853-539CC03D-05BF-410A-8A25-958BF05219CBQ30500898-37127BA0-251B-4882-B906-F319F8E686B6Q33769952-563C49E5-7B04-43B8-9B8E-F409E031CFD7Q33904273-15E230BB-F527-4046-83FA-08EA53ABD37DQ34087938-1EEF385E-7562-4B6B-A9BD-EF0B1D13A4C3Q34963755-45C9A461-1A98-4B16-8526-7C114A95B47FQ35213003-983DD63F-16C3-4CFE-96FA-12EA6AABF5B3Q35529255-BE0C141C-8617-4108-A2B8-DBEAEC3EB0E6Q35785935-1BE94AAE-42C2-4D98-99C1-BFEC6FFB5A08Q36091339-38DD532F-478E-4591-91C1-DCE12AD5D074Q36174906-A8676DB5-59CB-4F25-B962-D935F65ACE37Q36591782-7569EE23-2C98-4510-9BF0-BC77D3660445Q37033330-AFDD3186-E1F7-43B0-85B9-DFBDBCE88E9EQ37050779-5450580B-17A8-4274-B710-CC9FF994B632Q37261170-9616BD16-0199-4C54-8340-D0D99A1C7396Q37301528-2A6ADF83-D92C-4548-91FF-21D54FC7C16CQ37348839-43F7F75F-73A4-4D0F-AB1B-E977EAC6A13AQ37791489-4948F9BE-5D0E-46B8-9446-519358F5FA0DQ37983788-B5BD33CC-1A11-4548-BB55-C4070A98B546Q38034611-94E47E57-75A2-49BE-8D9D-7AA63660E1FEQ38974101-7A5F6FAF-77CB-40A4-BEC8-32F89A5F4399Q42000292-DEFEA468-B870-4491-82B5-C45B66F64202Q43270590-B4ECF3CA-8E67-40DC-B18D-08B23419CD5CQ44710137-685DB9C0-84D2-4380-8CAD-BD11265FD661Q48891652-CBFFF999-2820-4229-BDD6-FC302497D9B4Q48892536-21F9601C-E11C-445C-B797-4DFA5BC0FAF0Q51586474-6BA4A312-C4DB-48D9-86E2-3A29DB99E0B8Q57813696-C3076482-2A84-4367-B16D-1C80F544289F
P2860
Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Upregulation of transcription ...... in multiple sclerosis lesions.
@en
Upregulation of transcription ...... in multiple sclerosis lesions.
@nl
type
label
Upregulation of transcription ...... in multiple sclerosis lesions.
@en
Upregulation of transcription ...... in multiple sclerosis lesions.
@nl
prefLabel
Upregulation of transcription ...... in multiple sclerosis lesions.
@en
Upregulation of transcription ...... in multiple sclerosis lesions.
@nl
P2093
P2860
P356
P1433
P1476
Upregulation of transcription ...... in multiple sclerosis lesions.
@en
P2093
De Groot CJ
Montagne L
Van Den Elsen PJ
Van Der Valk P
Van Zutphen M
P2860
P356
10.1002/GLIA.1096
P577
2001-10-01T00:00:00Z